4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-002139
CHIEF EXECUTIVE OFFICER acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2021-04-23 | Option exercise | +5,000 | $1.50 | $7,500 | 40,375 | D |
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2021-04-23 | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | D | ||
Loading xslF345X03/form4-04272021_010440.xml…